|
1
|
Schulze K, Imbeaud S, Letouzé E,
Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C,
Shinde J, Soysouvanh F, et al: Exome sequencing of hepatocellular
carcinomas identifies new mutational signatures and potential
therapeutic targets. Nat Genet. 47:505–511. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Urtasun R, Elizalde M, Azkona M, Latasa
MU, García-Irigoyen O, Uriarte I, Fernández-Barrena MG, Vicent S,
Alonso MM, Muntané J, et al: Splicing regulator SLU7 preserves
survival of hepatocellular carcinoma cells and other solid tumors
via oncogenic miR-17-92 cluster expression. Oncogene. 35:4719–4729.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu H, Han C and Wu T: MiR-17-92 cluster
promotes hepatocarcinogenesis. Carcinogenesis. 36:1213–1222. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sapre N and Selth LA: Circulating
MicroRNAs as biomarkers of prostate cancer: The state of play.
Prostate Cancer. 2013:5396802013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Song W, Yan X, Li A, Zhang X, Li W,
Wen X, Zhou L, Yu D, Hu JF and Cui J: Friend leukemia virus
integration 1 promotes tumorigenesis of small cell lung cancer
cells by activating the miR-17-92 pathway. Oncotarget.
8:41975–41987. 2017.PubMed/NCBI
|
|
8
|
Dhar S, Hicks C and Levenson AS:
Resveratrol and prostate cancer: Promising role for microRNAs. Mol
Nutr Food Res. 55:1219–1229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu F, Zhang F, Li X, Liu Q, Liu W, Song
P, Qiu Z, Dong Y and Xiang H: Prognostic role of miR-17-92 family
in human cancers: Evaluation of multiple prognostic outcomes.
Oncotarget. 8:69125–69138. 2017.PubMed/NCBI
|
|
10
|
Strickertsson JA, Rasmussen LJ and
Friis-Hansen L: Enterococcus faecalis infection and reactive oxygen
species Down-regulates the miR-17-92 cluster in gastric
adenocarcinoma cell culture. Genes (Basel). 5:726–738. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Knudsen KN, Nielsen BS, Lindebjerg J,
Hansen TF, Holst R and Sorensen FB: microRNA-17 Is the Most
Up-Regulated member of the miR-17-92 cluster during early colon
cancer evolution. PLoS One. 10:e01405032015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zou P, Ding J and Fu S: Elevated
expression of microRNA-19a predicts a poor prognosis in patients
with osteosarcoma. Pathol Res Pract. 213:194–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou B, Wang J, Zheng G and Qiu Z:
Methylated urolithin A, the modified ellagitannin-derived
metabolite, suppresses cell viability of DU145 human prostate
cancer cells via targeting miR-21. Food Chem Toxicol. 97:375–384.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song L, Liu S, Zhang L, Yao H, Gao F, Xu D
and Li Q: MiR-21 modulates radiosensitivity of cervical cancer
through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop
and the Akt-mTOR signaling pathway. Tumour Biol. 37:12161–12168.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li C, Song L, Zhang Z, Bai XX, Cui MF and
Ma LJ: MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal
transition in gastric cancer through up-regulating PTEN expression.
Oncotarget. 7:66989–67003. 2016.PubMed/NCBI
|
|
16
|
Fang H, Xie J, Zhang M, Zhao Z, Wan Y and
Yao Y: miRNA-21 promotes proliferation and invasion of
triple-negative breast cancer cells through targeting PTEN. Am J
Transl Res. 9:953–961. 2017.PubMed/NCBI
|
|
17
|
Dhar S, Kumar A, Rimando AM, Zhang X and
Levenson AS: Resveratrol and pterostilbene epigenetically restore
PTEN expression by targeting oncomiRs of the miR-17 family in
prostate cancer. Oncotarget. 6:27214–27226. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao D, Chen Y, Chen S, Zheng C, Hu J and
Luo S: MiR-19a regulates the cell growth and apoptosis of
osteosarcoma stem cells by targeting PTEN. Tumour Biol.
39:10104283177053412017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu G, Chen X, Chen S, Ye W, Hou K and
Liang M: MiR-19a, miR-122 and miR-223 are differentially regulated
by hepatitis B virus X protein and involve in cell proliferation in
hepatoma cells. J Transl Med. 14:1222016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma Q, Peng Z, Wang L, Li Y, Wang K, Zheng
J, Liang Z and Liu T: miR-19a correlates with poor prognosis of
clear cell renal cell carcinoma patients via promoting cell
proliferation and suppressing PTEN/SMAD4 expression. Int J Oncol.
49:2589–2599. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu K, Liu S, Zhang W, Jia B, Tan L, Jin Z
and Liu Y: miR-494 promotes cell proliferation, migration and
invasion, and increased sorafenib resistance in hepatocellular
carcinoma by targeting PTEN. Oncol Rep. 34:1003–1010. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Chen Y, Zhao P, Zang L, Zhang Z
and Wang X: MicroRNA-19a functions as an oncogene by regulating
PTEN/AKT/pAKT pathway in myeloma. Leuk Lymphoma. 58:932–940. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Xie W, Xie C, Huang C, Zhu J, Liang
Z, Deng F, Zhu M, Zhu W, Wu R, et al: Curcumin modulates
miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7
breast cancer cell proliferation. Phytother Res. 28:1553–1560.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aggarwal BB, Bhardwaj A, Aggarwal RS,
Seeram NP, Shishodia S and Takada Y: Role of resveratrol in
prevention and therapy of cancer: Preclinical and clinical studies.
Anticancer Res. 24:2783–2840. 2004.PubMed/NCBI
|
|
25
|
Wang G, Dai F, Yu K, Jia Z, Zhang A, Huang
Q, Kang C, Jiang H and Pu P: Resveratrol inhibits glioma cell
growth via targeting oncogenic microRNAs and multiple signaling
pathways. Int J Oncol. 46:1739–1747. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dhar S, Kumar A, Li K, Tzivion G and
Levenson AS: Resveratrol regulates PTEN/Akt pathway through
inhibition of MTA1/HDAC unit of the NuRD complex in prostate
cancer. Biochim Biophys Acta. 1853:265–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo H, Yang Y, Duan J, Wu P, Jiang Q and
Xu C: PTEN-regulated AKT/FoxO3a/Bim signaling contributes to
reactive oxygen species-mediated apoptosis in selenite-treated
colorectal cancer cells. Cell Death Dis. 4:e4812013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumar A, Rimando AM and Levenson AS:
Resveratrol and pterostilbene as a microRNA-mediated
chemopreventive and therapeutic strategy in prostate cancer. Ann N
Y Acad Sci. 1403:15–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Kong D, Wang Z and Sarkar FH:
Regulation of microRNAs by natural agents: An emerging field in
chemoprevention and chemotherapy research. Pharm Res. 27:1027–1041.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Milenkovic D, Jude B and Morand C: miRNA
as molecular target of polyphenols underlying their biological
effects. Free Radic Biol Med. 64:40–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu YR, Qi HJ, Deng DF, Luo YY and Yang SL:
MicroRNA-21 promotes cell proliferation, migration, and resistance
to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal
cancer. Tumour Biol. 37:12061–12070. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang G, Li Y, Wang P, Liang H, Cui M, Zhu
M, Guo L, Su Q, Sun Y, McNutt MA and Yin Y: PTEN regulates RPA1 and
protects DNA replication forks. Cell Res. 25:1189–1204. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang RM, Xu JF, Fang F, Yang H and Yang
LY: MicroRNA-130b promotes proliferation and EMT-induced metastasis
via PTEN/p-AKT/HIF-1α signaling. Tumour Biol. 37:10609–10619. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li P, Mao WM, Zheng ZG, Dong ZM and Ling
ZQ: Down-regulation of PTEN expression modulated by dysregulated
miR-21 contributes to the progression of esophageal cancer. Dig Dis
Sci. 58:3483–3493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang H, Kong W, He L, Zhao JJ, O'Donnell
JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV and Cheng JQ:
MicroRNA expression profiling in human ovarian cancer: miR-214
induces cell survival and cisplatin resistance by targeting PTEN.
Cancer Res. 68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
